ライフサイエンスコーパス: bone morphogenetic

1 itions and vascular calcification, including bone morphogenetic protein (BMP) and transforming growth

2 We found that modulation of bone morphogenetic protein (BMP) and WNT signaling combi

3 t in the context of reduced ShcA levels, the bone morphogenetic protein (BMP) antagonist chordin-like

4 We have recently shown that the bone morphogenetic protein (BMP) antagonist Gremlin 2 (G

5 cted gene aberrant in neuroblastoma (DAN), a bone morphogenetic protein (BMP) antagonist we detected

6 e that CHRDL1 encodes Ventroptin, a secreted bone morphogenetic protein (BMP) antagonist, the molecul

7 Hemojuvelin is a bone morphogenetic protein (BMP) co-receptor.

8 The bone morphogenetic protein (Bmp) family of secreted mole

9 The Bone Morphogenetic Protein (BMP) family reiteratively si

10 evelopment, with a classic example being the bone morphogenetic protein (BMP) gradient's conserved ro

11 Here we show that bone morphogenetic protein (BMP) growth factor signaling

12 iron homeostasis by direct interaction with bone morphogenetic protein (BMP) ligands to induce hepci

13 that injury stimulates the production of two bone morphogenetic protein (BMP) ligands, Dpp and Gbb, w

14 equencing (ChIP-seq) data, we identified the bone morphogenetic protein (BMP) pathway as a potential

15 Here we demonstrate that the bone morphogenetic protein (BMP) pathway can also be reg

16 The bone morphogenetic protein (BMP) pathway is essential fo

17 At diagnosis, deregulation of the bone morphogenetic protein (BMP) pathway is involved in

18 in particular the dual modulation of Wnt and bone morphogenetic protein (BMP) pathway signaling, this

19 on the transforming growth factor (TGF)-beta/bone morphogenetic protein (BMP) pathway, which is one o

20 ess of endodermal development, including the Bone morphogenetic protein (Bmp) pathway.

21 ransforming growth factor beta (TGFbeta) and bone morphogenetic protein (BMP) pathways.

22 Beta-catenin/Tcf and the TGF-beta bone morphogenetic protein (BMP) provide critical molecu

23 its surrogate surface marker P2RY1, and the bone morphogenetic protein (BMP) receptor 1A (BMPR1A)/ac

24 The bone morphogenetic protein (BMP) receptor Tkv localizes

25 ated that OA-MSC expressed the same level of Bone Morphogenetic Protein (BMP) Receptor-1A as OAC but

26 14-17 of CRIM1 (cysteine-rich transmembrane bone morphogenetic protein (BMP) regulator 1).

27 ransforming growth factor beta (TGFbeta) and bone morphogenetic protein (BMP) signal transduction in

28 red neogenic hair follicles, which triggered bone morphogenetic protein (BMP) signaling and then acti

29 cal and genetic epistasis studies identified bone morphogenetic protein (BMP) signaling as a mediator

30 To assess whether bone morphogenetic protein (BMP) signaling contributes t

31 We showed previously that SMOC inhibits bone morphogenetic protein (BMP) signaling downstream of

32 Loss of the growth-suppressive effects of bone morphogenetic protein (BMP) signaling has been demo

33 mice were carried out to assess the role of bone morphogenetic protein (BMP) signaling in psoriatic

34 lly cryptic "secondary cells." Inhibition of bone morphogenetic protein (BMP) signaling in secondary

35 result of differential regulation of Wnt and bone morphogenetic protein (BMP) signaling in these two

36 Bone morphogenetic protein (BMP) signaling is critical i

37 has been constructed and, here, we show that bone morphogenetic protein (BMP) signaling is essential

38 Bone morphogenetic protein (BMP) signaling is known to c

39 Here we show that hippocampal bone morphogenetic protein (BMP) signaling is modulated

40 function of an activity-dependent autocrine Bone Morphogenetic Protein (BMP) signaling pathway at th

41 The bone morphogenetic protein (BMP) signaling pathway compr

42 ibit Ras signaling and may also activate the bone morphogenetic protein (BMP) signaling pathway in co

43 coagulation factor fibrinogen activates the bone morphogenetic protein (BMP) signaling pathway in ol

44 Hepcidin expression is induced via the bone morphogenetic protein (BMP) signaling pathway that

45 In the anterior, it activates the bone morphogenetic protein (BMP) signaling pathway throu

46 rates that RNAi silencing of a member of the Bone Morphogenetic Protein (BMP) signaling pathway, Deca

47 f these mutants target the components of the Bone Morphogenetic Protein (BMP) signaling pathway, reve

48 Bone morphogenetic protein (BMP) signaling pathways cont

49 axis is established and patterned by Wnt and bone morphogenetic protein (BMP) signaling pathways, res

50 e through modulation of Hedgehog, Notch, and bone morphogenetic protein (BMP) signaling pathways.

51 A morphogen gradient of Bone Morphogenetic Protein (BMP) signaling patterns the

52 Bone morphogenetic protein (BMP) signaling performs mult

53 between transforming growth factor beta1 and bone morphogenetic protein (BMP) signaling plays an impo

54 The family of TGF-beta and bone morphogenetic protein (BMP) signaling proteins has

55 he transforming growth factor beta (TGFbeta)/bone morphogenetic protein (BMP) signaling system.

56 Bone morphogenetic protein (BMP) signaling was activated

57 y element-binding protein (SREBP) signaling, bone morphogenetic protein (BMP) signaling, and glycosyl

58 SMAD1/5 transcription factors, activated by bone morphogenetic protein (BMP) signaling, are major re

59 Multiple invasion pathways including EMT, bone morphogenetic protein (BMP) signaling, chemokine si

60 Although antagonists of bone morphogenetic protein (BMP) signaling, such as Nogg

61 elf-renewing SCs, Foxc1 activates Nfatc1 and bone morphogenetic protein (BMP) signaling, two key mech

62 per, notable for roles in Wingless (Wnt) and bone morphogenetic protein (BMP) signaling, were differe

63 es Wnt and Notch signaling while suppressing bone morphogenetic protein (BMP) signaling.

64 , and R-spondin signaling with inhibition of bone morphogenetic protein (BMP) signaling.

65 TGF-beta and activin signals while enhancing bone morphogenetic protein (BMP) signaling.

66 and TSP-14, function redundantly to promote bone morphogenetic protein (BMP) signaling.

67 al in the Drosophila ovary where it enhances bone morphogenetic protein (BMP) signaling.

68 function, and their dysregulating effect on bone morphogenetic protein (BMP) signaling.

69 nd transforming growth factor-beta (TGFbeta)/bone morphogenetic protein (BMP) signalling and illustra

70 wingless-related integration site (WNT), and bone morphogenetic protein (BMP) signalling interactions

71 es from a murine myeloma model, we find that bone morphogenetic protein (BMP) signalling is upregulat

72 n coupled fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) signalling together wit

73 s myocardial trabeculation through Erbb2 and bone morphogenetic protein (BMP) signalling, we discover

74 process enhanced by mating and controlled by bone morphogenetic protein (BMP) signalling.

75 pression and signaling are up-regulated, and bone morphogenetic protein (BMP) signals are impaired.

76 In the Drosophila ovarian germline, Bone Morphogenetic Protein (BMP) signals released by nic

77 and Wnt/beta-catenin) or share (TGFbeta and bone morphogenetic protein (BMP)) core signaling compone

78 wingless-integrated site (Wnt)/beta-catenin, bone morphogenetic protein (Bmp), and fibroblast growth

79 This data shows that Wnt, bone morphogenetic protein (BMP), and fibroblast growth

80 ys, epidermal growth factor receptor (EGFR), bone morphogenetic protein (BMP), Jun kinase (JNK), JAK/

81 dels commonly increase signaling of the Wnt, bone morphogenetic protein (BMP), or Ras/ERK pathways, c

82 FE) is specified by sequential inhibition of bone morphogenetic protein (BMP), transforming growth fa

83 ial cells (recell-dTBs); 3) dTBs seeded with bone morphogenetic protein (BMP)-2 (dTB-BMPs); and 4) fr

84 Bone morphogenetic protein (BMP)-2 is used clinically fo

85 owth factor (TGF)-beta family, TGF-beta1 and bone morphogenetic protein (BMP)-2, in synovial fibrobla

86 s of inducible nitric oxide synthase (iNOS), bone morphogenetic protein (BMP)-2, matrix metalloprotei

87 nd that iSMCs from HGPS donors overexpressed bone morphogenetic protein (BMP)-4, which plays a key ro

88 The bone morphogenetic protein (BMP)-Smad signaling pathway

89 The bone morphogenetic protein (BMP)-SMAD signaling pathway

90 receptor and function as coreceptors for the bone morphogenetic protein (BMP)/growth differentiation

91 mone hepcidin, which is regulated by hepatic bone morphogenetic protein (BMP)/SMAD signalling.

92 ad2/3 pathway and activation of the parallel bone morphogenetic protein (BMP)/Smad1/5 axis (recently

93 was accompanied by changes in expression of bone morphogenetic protein (BMP)/sons of mothers against

94 ymatic activity, and six were members of the bone morphogenetic protein (BMP)/TGF-beta pathway.

95 es the gene encoding hepcidin (HAMP) via the bone morphogenetic protein (BMP)6 signaling to SMAD.

96 Bone morphogenetic protein (BMP)9 is a circulating growt

97 d that mutations in the type II receptor for bone morphogenetic protein (BMPRII) underlie the majorit

98 s of VBA, with and without recombinant human bone morphogenetic protein (rhBMP)-2, under space-making

99 und that the extracellular metalloproteinase bone morphogenetic protein 1 (BMP-1) is involved in endo

100 en processing by the C-propeptide proteinase bone morphogenetic protein 1 (BMP-1).

101 Mutations in bone morphogenetic protein 1 (BMP1) in humans or deletio

102 ntified the secreted zinc metalloproteinase, bone morphogenetic protein 1 (BMP1), as responsible for

103 es the cleavage of C-terminal procollagen by bone morphogenetic protein 1 (BMP1).

104 C1r/C1s, urchin embryonic growth factor, and bone morphogenetic protein 1 domain indicate that Mt2I28

105 einase with thrombospondin motifs) and BMP1 (bone morphogenetic protein 1)/Tolloid-like families, res

106 Bone morphogenetic protein 10 (BMP10), one member of the

107 Growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are secreted durin

108 terms of osteoblastic differentiation using bone morphogenetic protein 2 (BMP-2) added to the medium

109 ential delivery of essential growth factors, bone morphogenetic protein 2 (BMP-2) and vascular endoth

110 Parbendazole up-regulates bone morphogenetic protein 2 (BMP-2) gene expression and

111 Although bone morphogenetic protein 2 (BMP-2) is known to stimula

112 determining role of these residues, BG bound bone morphogenetic protein 2 (BMP-2) weakly or not at al

113 In calcified arteries, bone morphogenetic protein 2 (BMP-2)levels were increase

114 The expressions of bone morphogenetic protein 2 (BMP2) and BMP6; sex-determ

115 study, we discovered the double deletion of bone morphogenetic protein 2 (Bmp2) and bone morphogenet

116 Bone morphogenetic protein 2 (BMP2) in chromosomal regio

117 Bone morphogenetic protein 2 (BMP2) promotes PF formatio

118 Otic-specific knockout of bone morphogenetic protein 2 (Bmp2) results in absence o

119 e previously identified a nuclear variant of bone morphogenetic protein 2 (BMP2), named nBMP2, that i

120 Recombinant human bone morphogenetic protein 2 (rhBMP-2) is an osteoinduct

121 GO with the growth factor recombinant human bone morphogenetic protein 2 (rhBMP-2), producing a scaf

122 ated osteoblast mineralization by regulating bone morphogenetic protein 2 and p53.

123 A bone morphogenetic protein 2 gradient, presented across

124 ptide nanostructures amplified signalling of bone morphogenetic protein 2 significantly more than the

125 Bone morphogenetic protein 2-inducible kinase (BMP2K) ha

126 les, histochemical, and immunohistochemical (bone morphogenetic protein 2/4 [BMP2/4], osteocalcin [OC

127 Furthermore, bone morphogenetic protein 4 (BMP-4), which also induces

128 n of bone morphogenetic protein 2 (Bmp2) and bone morphogenetic protein 4 (Bmp4) in the dental epithe

129 response to transient (24-36 h) exposure to bone morphogenetic protein 4 (BMP4) plus inhibitors of A

130 coprotein 1 (GLG1) expression and downstream bone morphogenetic protein 4 (BMP4) signaling and also r

131 es different concentrations of activin A and bone morphogenetic protein 4 (BMP4) to polarize cells in

132 peri-gastrulation-like fate patterning upon bone morphogenetic protein 4 (BMP4) treatment of geometr

133 We show that bone morphogenetic protein 4 (BMP4), an important differ

134 We and others showed that Bone Morphogenetic Protein 4 (BMP4), and other BMPs are

135 TGF-beta signaling mediated by pSMAD2, bone morphogenetic protein 4 (BMP4), EGF, or PDGF was un

136 Consequently, bone morphogenetic protein 4 (BMP4), or ectopic expressi

137 own to promote beta-cell function, including bone morphogenetic protein 4 (BMP4).

138 Contributions of bone morphogenetic protein 4 and transforming growth fac

139 le protocol, using defined medium containing bone morphogenetic protein 4 by which human pluripotent

140 Bone morphogenetic protein 4 up-regulated alphaB-crystal

141 e, miR-18a decreased the expression of BMP4 (bone morphogenetic protein 4) and HIF-1alpha (hypoxia-in

142 ons becomes CDNF-dependent after exposure to bone morphogenetic protein 4.

143 Bone morphogenetic protein 6 (BMP6) contributes to the i

144 Recent work has suggested that increased bone morphogenetic protein 6 (BMP6) expression could alt

145 Lack of either bone morphogenetic protein 6 (BMP6) or the BMP corecepto

146 Bone morphogenetic protein 6 (BMP6) signaling in hepatoc

147 ether these molecules intersect in vivo with bone morphogenetic protein 6 (BMP6)/mothers against deca

148 Its expression is regulated by the bone morphogenetic protein 6 (BMP6)/SMAD1/5/8 pathway an

149 ivary gland fluid secretion, is regulated by bone morphogenetic protein 6.

150 ansforming growth factor beta (TGFbeta), and bone morphogenetic protein 7 (BMP7), CD1c(+) dendritic c

151 We further identify bone morphogenetic protein 7 as one of them.

152 8 also increased renal expression of klotho, bone morphogenetic protein 7, and Smad7.

153 VEGF-A, VEGF-C, VEGF-D, VEGF-A isoform 121, bone morphogenetic protein 7, macrophage colony-stimulat

154 sue into endocrine cell types by exposure to bone morphogenetic protein 7.

155 (drMM) in the presence of human recombinant bone morphogenetic protein 7/human recombinant fibroblas

156 cluding fibroblast growth factor 21 (FGF21), bone morphogenetic protein 8b (BMP8b), growth differenti

157 d endothelial cell signalling in response to bone morphogenetic protein 9 (BMP9) and BMP10 is of sign

158 Bone morphogenetic protein 9 (BMP9) is a circulating fac

159 Circulating bone morphogenetic protein 9 (BMP9), a vascular quiescen

160 T is caused by loss-of-function mutations in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signa

161 r-like kinase 1 (ALK1), endoglin, Smad4, and bone morphogenetic protein 9 (BMP9).

162 BMP9 (bone morphogenetic protein 9) is a circulating endotheli

163 recipitation-sequencing experiments on BMP9 (bone morphogenetic protein 9)-stimulated endothelial cel

164 T signaling did not significantly affect the bone morphogenetic protein activity.

165 We found an interaction between WNT, bone morphogenetic protein and hedgehog signalling with

166 otein negatively regulates the activities of bone morphogenetic protein and phosphoinositide 3-kinase

167 To address whether elevated activities of bone morphogenetic protein and PI3K/AKT signaling pathwa

168 valves demonstrated activation of canonical bone morphogenetic protein and Wnt/beta-catenin signalin

169 cardiogenic fate of CNC(kit) is regulated by bone morphogenetic protein antagonism, a signaling pathw

170 expression of the gene encoding mesenchymal bone morphogenetic protein antagonist, GREM1.

171 ase inhibitors, activin traps, hepcidin, and bone morphogenetic protein antagonists in treating cance

172 channels regulate release of the Drosophila bone morphogenetic protein Dpp in the developing fly win

173 show that the bone morphogenetic protein gradient is decoded through f

174 el, calcium deposition and the expression of bone morphogenetic protein isoform (BMPs).

175 Treatment with bone morphogenetic protein or SHH pathway inhibitors dec

176 GDF7 (rs3072), which encodes a ligand in the bone morphogenetic protein pathway, and TBX5 (rs2701108)

177 We analyzed the effect of Irf8 on TGF-beta/bone morphogenetic protein pathway-specific genes in DCs

178 /or cocaine due to severe down-modulation of bone morphogenetic protein receptor (BMPR) axis: the ant

179 ce suggests that serotonin, mutations in the bone morphogenetic protein receptor (BMPR) II gene, and

180 e mutations leading to reduced expression of bone morphogenetic protein receptor (BMPR) II, these mut

181 Monoallelic mutations in the gene encoding bone morphogenetic protein receptor 2 ( Bmpr2) are the m

182 The effect of a mutation in the bone morphogenetic protein receptor 2 (BMPR2) gene on ri

183 Because decreased expression and function of bone morphogenetic protein receptor 2 (BMPR2) is observe

184 terized by endothelial dysfunction, impaired bone morphogenetic protein receptor 2 (BMPR2) signaling,

185 hat in SMC and EC contact cocultures, BMPR2 (bone morphogenetic protein receptor 2) is required by bo

186 with hyperactivating mutations of the type I bone morphogenetic protein receptor ACVR1 (Activin type

187 However, transforming growth factor beta and bone morphogenetic protein receptor II signaling, and hy

188 role of transforming growth factor beta and bone morphogenetic protein receptor II signaling, human

189 ifferential transforming growth factor beta, bone morphogenetic protein receptor II signaling, or car

190 CLIC4 reduced BMPRII (bone morphogenetic protein receptor II) expression and s

191 tion of SMAD1 by activin A receptor type 1L, bone morphogenetic protein receptor type 1A, and bone mo

192 morphogenetic protein receptor type 1A, and bone morphogenetic protein receptor type 1B and phosphor

193 Expression of bone morphogenetic protein receptor type 2 (BMPR2) and i

194 erozygous mutations in the gene encoding the bone morphogenetic protein receptor type 2 (BMPR2) are t

195 ith heritable PAH caused by mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene

196 l hypertension with germline mutation in the bone morphogenetic protein receptor type 2 (BMPR2) gene,

197 despite clinical and molecular similarity to bone morphogenetic protein receptor type 2 mutation-asso

198 BMPR2 (bone morphogenetic protein receptor type 2) mutations ac

199 Mutations in the gene encoding the bone morphogenetic protein receptor type II (BMPR2) are

200 n PASMCs from PAH patients with mutations in bone morphogenetic protein receptor type II.

201 duced aggregation; 2) rs11202221, in BMPR1A (bone morphogenetic protein receptor type1A), replicated

202 sed to track the expression of a manipulated bone morphogenetic protein receptor within the Brainbow

203 in accumulation of synaptic growth-promoting bone morphogenetic protein receptors in the cell body an

204 In addition, the reduction in bone morphogenetic protein signaling and Shotgun express

205 However, inhibition of bone morphogenetic protein signaling caused a significan

206 G85R) We found cell-autonomous activation of bone morphogenetic protein signaling in proprioceptor se

207 ith our demonstration that the activation of bone morphogenetic protein signaling in proprioceptors a

208 n-regulatory hormone that is induced via the bone morphogenetic protein signaling pathway.

209 (Wnt), transforming growth factor-beta, and bone morphogenetic protein signaling pathways affect car

210 rse transcriptional programs associated with bone morphogenetic protein signaling, alveolar specifica

211 R/MEK/Erk1/2 signaling and downregulation of bone morphogenetic protein signaling, with negative and

212 ed either by erythroferrone or by inhibiting bone morphogenetic protein signaling.

213 onic axis depends on a morphogen gradient of Bone Morphogenetic Protein signaling.

214 showed that loss of PEAT modestly increases bone morphogenetic protein target gene expression and al

215 fferentially expressed genes were related to bone morphogenetic protein type 2 receptor (BMPR2) signa

216 ty of HPAH patients inherit mutations in the bone morphogenetic protein type 2 receptor gene (BMPR2),

217 DNA damage and impaired signaling of BMPR2 (bone morphogenetic protein type 2 receptor) via two down

218 Mutations in the bone morphogenetic protein type-II receptor (BMPR-II) ar

219 Heterozygous germ-line mutations in the bone morphogenetic protein type-II receptor (BMPR-II) ge

220 ENG (endoglin) is a coreceptor for BMP (bone morphogenetic protein) 9/10 and is strongly express

221 BMP9 and BMP10 (bone morphogenetic protein) are known to regulate endoth

222 Decapentaplegic, a homolog of the vertebrate bone morphogenetic protein) from the wing imaginal disc.

223 BMP (bone morphogenetic protein) signaling activity is precis

224 tor cyclin-dependent kinase 1 decreases BMP (bone morphogenetic protein) signaling activity specifica

225 GDF2 encodes the circulating BMP (bone morphogenetic protein) type 9, which is a ligand fo

226 ntiation and new bone formation through WNT, bone morphogenetic protein, and Notch signaling pathways

227 ation of Hedgehog, fibroblast growth factor, bone morphogenetic protein, and Wnt signaling in the gen

228 , Indian hedgehog, fibroblast growth factor, bone morphogenetic protein, and Wnt signaling pathways i

229 ignaling pathways, including Sonic hedgehog, bone morphogenetic protein, fibroblast growth factor, tr

230 niche signalling pathways, specifically Wnt, bone morphogenetic protein, Notch and epidermal growth f

231 The four members of the family: bone morphogenetic protein-1 (BMP-1), mammalian tolloid

232 Here we show that bone morphogenetic protein-1 (BMP1)/Tolloid (TLD)-like p

233 ts C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains (distal domains).

234 ts C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains.

235 lial growth factor A (VEGFA), interleukin-2, bone morphogenetic protein-10, VEGFC, and 2 (FGF2) were

236 Growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are co-expressed e

237 rently, sustained in vivo delivery of active bone morphogenetic protein-2 (BMP-2) protein to responsi

238 ch as fibroblast growth factor-2 (FGF-2) and bone morphogenetic protein-2 (BMP-2) work synergisticall

239 ECFCs produced bone morphogenetic protein-2 (BMP-2), a potent osteoindu

240 gulates differentiation of OCs downstream of bone morphogenetic protein-2 (BMP-2)-stimulated osteobla

241 l with a collagen scaffold soaked in saline, bone morphogenetic protein-2 (BMP-2; 200 ng), 1 muM CGS2

242 al and temporal release of recombinant human bone morphogenetic protein-2 (BMP2) and vascular endothe

243 Although bone morphogenetic protein-2 (BMP2) has demonstrated ext

244 on of mesenchymal stem cells (MSCs), whereas bone morphogenetic protein-2 (BMP2) promotes osteogenic

245 The bone marrow cryogel (BMC) releases bone morphogenetic protein-2 to recruit stromal cells an

246 In osteoblasts, CypA is necessary for BMP-2 (Bone Morphogenetic Protein-2)-induced Smad phosphorylati

247 tor (RUNX)-2, integrin binding sialoprotein, bone morphogenetic protein-2, osteocalcin, and cementum

248 In the present study, bone morphogenetic protein-2/BMP-2-directed osteogenic d

249 Here, we show that bone morphogenetic protein-4 (BMP4) blocks metastasis in

250 Bone morphogenetic protein-4 (BMP4) plays a key role in

251 es for hESC differentiated to TB by means of bone morphogenetic protein-4 and inhibitors of activin A

252 t Six1 and Six2 regulate both endothelin and bone morphogenetic protein-4 signaling pathways to patte

253 echanisms involved revealed the induction of bone morphogenetic protein-7 (BMP7) expression, a critic

254 We evaluated the effects of THR-184, a bone morphogenetic protein-7 agonist, in patients at hig

255 Bone morphogenetic protein-9 (BMP-9) is a circulating cy

256 Our objective is to determine circulating Bone morphogenetic protein-9(BMP-9) levels in subjects w

257 ilarly, wild-type (WT) animals, in which the bone morphogenetic protein-mothers against decapentapleg

258 ving hemojuvelin and other components of the bone morphogenetic protein-signaling pathway.

259 ar stress driven and downstream of canonical bone morphogenetic protein-SMAD signaling.

260 es with sLR11 inhibits thermogenesis via the bone morphogenetic protein/TGFbeta signalling pathway an

261 ay), and that they activate cardioprotective bone-morphogenetic-protein signalling in cardiomyocytes.

262 Exogenous bone morphogenetic proteins (Bmp) are well known to indu

263 f CR-CSCs to chemotherapy and the ability of bone morphogenetic proteins (BMP) to promote colonic ste

264 An activating bone morphogenetic proteins (BMP) type I receptor ACVR1

265 Bone morphogenetic proteins (BMP), part of the TGFbeta s

266 thelial serine-threonine kinase receptor for bone morphogenetic proteins (BMPs) 9 and 10.

267 glands are specified by mesenchymal-derived bone morphogenetic proteins (BMPs) and fibroblast growth

268 Bone morphogenetic proteins (BMPs) are growth factors th

269 Bone morphogenetic proteins (BMPs) are important mediato

270 Bone morphogenetic proteins (BMPs) are members of the TG

271 Bone morphogenetic proteins (BMPs) are multifunctional c

272 Bone morphogenetic proteins (BMPs) are secreted cytokine

273 Bone morphogenetic proteins (BMPs) are secreted growth f

274 Bone morphogenetic proteins (BMPs) are secreted ligands

275 Bone morphogenetic proteins (BMPs) are secreted proteins

276 Bone morphogenetic proteins (BMPs) are TGF-beta family m

277 Since the discovery of bone morphogenetic proteins (BMPs) as pluripotent cytoki

278 Subsequent treatment with bone morphogenetic proteins (BMPs) enhanced differentiat

279 the K19/14 sites in the promoter regions of bone morphogenetic proteins (BMPs) genes, which were ass

280 trauma with an osteo-inductive agent such as bone morphogenetic proteins (BMPs) has been considered a

281 gnaling involves binding to and sequestering bone morphogenetic proteins (BMPs) in the extracellular

282 In Xenopus laevis, bone morphogenetic proteins (Bmps) induce expression of

283 rcomes the inhibitory effect of lung-derived bone morphogenetic proteins (BMPs) on self-renewal and t

284 Bone Morphogenetic Proteins (BMPs) pattern the dorsal-ve

285 Bone morphogenetic proteins (BMPs) play key roles in the

286 Bone morphogenetic proteins (BMPs) regulate diverse cell

287 anoid cultures, such as those involving Wnt, bone morphogenetic proteins (BMPs), Notch, and Hedgehog

288 ignaling by Sonic hedgehog (SHH) followed by Bone morphogenetic proteins (BMPs), regulate a dynamic e

289 ly includes TGFbeta, activins, inhibins, and bone morphogenetic proteins (BMPs).

290 fferentiate into preosteoblasts that produce bone morphogenetic proteins (BMPs).

291 nd subsequent transcriptional suppression of bone morphogenetic proteins 5 and 7.

292 hat supplementation of exogenous recombinant bone morphogenetic proteins 7 effectively ameliorates en

293 Bone morphogenetic proteins 9 and 10 (BMP9/BMP10) are ci

294 operate locally (e.g., Wingless/Ints [Wnts], Bone Morphogenetic Proteins [BMPs], and Hedgehogs [Hhs])

295 decapentaplegic (dpp), the homolog of human bone morphogenetic proteins BMP2 and BMP4, is a muscle-s

296 Bone morphogenetic proteins BMP2 and BMP6 play key roles

297 dysregulated transforming growth factor beta/bone morphogenetic proteins signaling and that this imba

298 ing, and that ligandless activity in the TGF/bone morphogenetic proteins signaling pathway contribute

299 The BMPs (bone morphogenetic proteins) are essential morphogens in

300 olic genes such as Sox9, Col2a1, and Acan by bone morphogenetic proteins.